Research Article | | Peer-Reviewed

Chronic Vulvar Discomfort: Clinical Profiles, Pain Mapping, and Diagnostic Insights

Received: 12 April 2025     Accepted: 21 April 2025     Published: 22 May 2025
Views:       Downloads:
Abstract

This study provides a comprehensive clinical evaluation of women with chronic vulvar discomfort (CVD), focusing on two primary conditions underlying these symptoms: vulvodynia and vulvar dermatoses. A total of 328 women were enrolled in the DATRIV study (Diagnostic Accuracy of Three Rings Vulvoscopy) and categorized into four clinical groups: asymptomatic women with a normal vulva, asymptomatic women with impaired vulvar skin, and symptomatic patients diagnosed with either vulvodynia or vulvar dermatosis. Each participant underwent structured symptom profiling, sexual activity assessment, and targeted pain localization using the cotton-swab (Q-tip) test, systematically applied across a novel three-ring anatomical model (outer, middle, and inner vulvar rings). Pain response was further mapped using a clock-face method. Dyspareunia severity was graded with the Marinoff Index, and potential symptom triggers were explored through standardized behavioral and environmental questionnaires. Clinical data were analyzed using StatSoft, Statistica 12, and SPSS 20. The Institutional Review Board of Polyclinic Harni approved the study, and all participants provided written informed consent. Findings showed that 100% of women with vulvodynia and 80.5% of those with vulvar dermatoses experienced dyspareunia (Marinoff grades 1–3), in contrast to only 1.3% of asymptomatic controls. Marinoff Index 2 (pain that occasionally prevents intercourse) was observed in 54.8% of vulvodynia and 52.9% of dermatosis patients. In comparison, Marinoff Index 3 (pain that completely precludes intercourse) was present in 15.1% and 26.5%, respectively. Pain mapping revealed that the inner vulvar ring, especially at 4, 6, and 8 o’clock, was the most pain-sensitive region in patients with vulvodynia, consistent with localized nociceptor hypersensitivity. Environmental and behavioral triggers—such as menstruation (54.9% in vulvodynia vs. 36.5% in dermatosis), tampon use (65.9% vs. 42.8%), urination-related discomfort (47.6% vs. 36.6%), cycling (61.9% vs. 47.4%), and tight clothing (reported symptom aggravation in 85.4% of vulvodynia patients vs. 46.3% of dermatosis patients)—were frequently identified, reflecting distinct trigger profiles between the conditions. This study highlights the diagnostic value of combining the Marinoff Index and cotton-swab test with structured pain mapping using the three-ring vulvar model and clock-face method. Together, these tools offer a reproducible and clinically meaningful framework for identifying vulvar pain phenotypes, enabling more individualized and effective therapeutic strategies for women with chronic vulvar pain syndromes.

Published in Journal of Gynecology and Obstetrics (Volume 13, Issue 3)
DOI 10.11648/j.jgo.20251303.11
Page(s) 35-47
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Chronic Vulvar Discomfort, Vulvodynia, Vulvar Dermatosis, Dyspareunia, Three Vulvar Rings, Cotton-Swab Test, Marinoff Index

References
[1] Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc. 2003; 58(2): 82–88. PMID: 12744420.
[2] Reed BD, Haefner HK, Harlow SD, Gorenflo DW, Sen A. Reliability and validity of self-reported symptoms for predicting vulvodynia. Obstet Gynecol. 2006; 108(4): 906–913.
[3] Bachmann GA, Rosen R, Pinn VW, Utian WH, Ayers C, Basson R. Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med. 2006; 51(6): 447–456. PMID: 16822399.
[4] Leclair CM, Goetsch MF, Korcheva VB, Anderson R, Peters D, Morgan TK. Differences in primary compared with secondary vestibulodynia by immuno-histochemistry. Obstet Gynecol. 2011; 117(6): 1307–1313.
[5] Reed BD, Harlow SD, Sen A, et al. Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am J Obstet Gynecol. 2012; 206(2): 170. e1–170.e9.
[6] Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, et al. The tampon test for vulvodynia: a feasible standardized test for multisite vulvar pain. Am J Obstet Gynecol. 2009; 200(5): e1–e7.
[7] Lynch PJ. Vulvodynia: a syndrome of unexplained vulvar pain, burning, and irritation. Dermatol Ther. 2004; 17(1): 8–13.
[8] Bornstein J, Goldstein AT, Stockdale CK, et al. 2015 ISSVD, ISSWSH and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. J Low Genit Tract Dis. 2016; 20(2): 126–130.
[9] Krapf JM, Mitchell L, Goldstein AT. Vulvar lichen sclerosus: current perspectives. Int J Womens Health. 2020; 12: 11–20.
[10] Pawłowicz P, Nowak I, Szyllo K, Baran W. Vulvar lichen sclerosus – clinical presentation and management. Ginekologia Polska. 2021; 92 (3): 225–229.
[11] Cooper SM, Gao XH, Powell JJ. Lichen sclerosus. Clin Exp Dermatol. 2004; 29 2): 138 – 143.
[12] Foster DC, Kotok MB, Huang LS, et al. Histologic evidence of neuroproliferation and inflammation in vulvar vestibulitis syndrome. Obstet Gynecol. 2007; 109 (2 Pt 1): 371–376.
[13] Pukall CF, Goldstein AT, Bergeron S, et al. Vulvodynia: definition, prevalence, impact, and pathophysiological factors. J Sex Med. 2016; 13(3): 291–304. PMID: 2694461
[14] Moyal-Barracco M, Lynch PJ. 2004 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med. 2004; 49(10): 772–777. PMID: 15568399.
[15] Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol. 2003; 189(3 Suppl): S24–S30.
[16] Petersen CD, Giraldi A, Lundvall L, Kristensen E. Vulvodynia: definition, diagnosis, and treatment. Acta Obstet Gynecol Scand. 2008; 87(9): 893–901.
[17] Gunter J. Vulvodynia: diagnosis and management. Am Fam Physician. 2011; 83(6): 745–750. PMID: 214504986
[18] Goldstein AT, Pukall CF, Brown C, et al. Vulvodynia: assessment and treatment. J Sex Med. 2016; 13(4): 572–590.
[19] Petersen CD, Lundvall L, Kristensen E, Giraldi A. Vulvodynia—a multifactorial condition. J Reprod Med. 2009; 54(3): 153–160. PMID: 19301418.
[20] Krapf JM, Goldstein AT. Diagnosis and treatment of vulvar dermatoses. Clin Obstet Gynecol. 2015; 58(3): 540–555.
[21] Foster DC, Dworkin RH. Vulvodynia: current concepts and treatment approaches. Clin Obstet Gynecol. 2005; 48(4): 682–694.
[22] Goldstein AT, Pukall CF, Brown C, Bergeron S, Stein A, Kellogg-Spadt S. Vulvodynia: diagnosis and management. Clin Obstet Gynecol. 2017; 60(3): 453–465.
[23] Reed BD, Haefner HK, Punch MR, Roth RS, Gorenflo DW. Psychosocial and sexual correlates of vulvodynia. Obstet Gynecol. 2000; 95(5): 585–591.
[24] Michels TC, Krohn K. Evaluation and management of female sexual pain. Am Fam Physician. 2018; 97(7): 457–465. PMID: 29671530.
[25] Marinoff SC, Turner ML. Vulvar vestibulitis syndrome: a clinical approach. Obstet Gynecol. 1986; 67(4): 499–503. PMID: 3960437.
[26] Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000; 26(2): 191–208.
[27] Sutton KS, Pukall CF, Wild C, et al. The Vulvodynia Impact Questionnaire (VIQ): a measure of the psychological, relational, and sexual impact of vulvodynia. J Sex Med. 2009; 6(7): 1906–1915.
[28] Harni V, Babic D, Hadzavdic S, Barisic D. Basic Characteristics and Demographic Data in Patients with Chronic Vulvar Discomfort: A Detailed Analysis of DATRIV Study. Journal of Gynecology and Obstetrics. 2024; 12(2): 35-45
[29] Powell J, Wojnarowska F. Lichen sclerosus. Lancet. 1999; 353(9166): 1777–1783.
[30] Neill SM, Lewis FM, Tatnall FM, Cox NH; British Association of Dermatologists. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010; 163(4): 672–682.
[31] Moyal-Barracco M, Wendling J, Yeoman L, Edwards L. Vulvar dermatoses: a clinical and histopathologic review of 236 cases. Eur J Dermatol. 1999; 9(4): 264–269. PMID: 10356424.
[32] Reed BD, Harlow SD, Sen A, et al. Comorbid pain conditions and risk of new-onset vulvodynia. J Womens Health (Larchmt). 2012; 21(6): 695–700. PMID: 22468698
[33] Harni V, Babic D, Hadzavdic S, Barisic D, Karadza M. Comorbidity Pattern and Autonomic Nervous System Dysfunction in Patients with Chronic Vulvar Discomfort. Journal of Gynecology and Obstetrics. 2024; Vol. 12, No. 6, 118-131.
[34] Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009; 10(9): 895–926.
[35] Chialvo DR. From pain to pleasure: how the brain processes aversive stimuli. PLoS Biol. 2006; 4(3): e73.
[36] Janig W, Baron R. The role of the sympathetic nervous system in neuropathic pain: clinical and experimental evidence. Brain. 2002; 125(2): 219–240.
[37] Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014; 311(15): 1547–1555.
[38] Massad LS, Jeronimo J, Katki HA, Schiffman M. The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2009; 13(3): 137–144.
[39] Sideri M, Jones RW, Wilkinson EJ, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med. 2005; 50(11): 807–810. PMID: 16372862.
[40] Harni V, Babić D, Barišić D. "Three Rings Vulvoscopy" – A New Approach to the Vulva. Gynaecol Perinatol 2015; 24 (1): 37-45.
[41] Harni V, Babic D, Barisic D, Hadzavdic S. Diagnostic Accuracy of the Three Rings Vulvoscopy for Detection of Vulvar Dermatosis. J Low Genital Tract Disease 2019; Vol. 23 (4); Supp 1; S63.
[42] Harni V, Babic D, Hadzavdic S, Barisic D. Diagnostic Accuracy of the Vulvoscopy Index for Detection of Vulvar Dermatosis (DATRIV Study, Part 1). Journal of Gynecology and Obstetrics 2022; Vol. 10, No. 1, 39-47.
[43] Harni V, Babic D, Hadzavdic S, Barisic D. Clinical Value of the N-S-P Scheme for Detection of Vulvar Dermatosis (DATRIV Study, Part 2). Journal of Gynecology and Obstetrics 2022; Vol. 10, No. 3, 159-166.
[44] Cox JT. Management of vulvar intraepithelial neoplasia. Obstet Gynecol Clin North Am. 1996; 23(4): 735–754. PMID: 8954648.
[45] Van Beurden M, ten Kate FJW, Smits HL, et al. Vulvar intraepithelial neoplasia: the risk of progression and the role of biopsy. Obstet Gynecol. 1994; 84(5): 765–769.
[46] Harni V, Babic D, Hadzavdic S, Barisic D. Nonspecific Lesions in Patients with Chronic Vulvar Discomfort Revealed Vulvodynia as Chronic Reflex Pain Syndrome (CRPS) Type I. Journal of Gynecology and Obstetrics. 2022; 10(6): 243–252.
[47] Crystle CD, Charme LS, Archer DF. A new technique for physical examination of patients with vulvar vestibulitis. Obstetrics & Gynecology. 1981; 58(5): 590–594.
[48] Friedrich EG Jr. Vulvar vestibulitis syndrome. Journal of Reproductive Medicine. 1987; 32(2): 110–114.
[49] Haefner HK, Collins ME, Davis GD, et al. The Vulvodynia Guideline. Journal of Lower Genital Tract Disease. 2005; 9(1): 40–51.
[50] Byrne MA, Walker MM, Leonard J, Pryce D, Taylor-Robinson D. Recognising covert disease in women with chronic vulval symptoms attending an STD clinic: value of detailed examination including colposcopy. Genitourin Med 1989; 65: 46-9.
[51] Audisio T, Zarazaga J, Vainer O. A Classification of Vulvoscopic Findings for Clinical Diagnosis. J Lower Genit Tract Dis 1999; 3: 7-18.
[52] Julian T. Vulvar Pain: Diagnoses, Evaluation, and Management. J Lower Genit Tract Dis 1997; 1(3): 185-94.
[53] Stockdale CK, Lawson HW. 2013 Vulvodynia Guideline update. J Low Genit Tract Dis 2014; 18: 93–100.
[54] Goetsch MF. Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol. 1991; 164(6 Pt 1): 1609–1616. PMID: 1646560
[55] Edwards L. Vulvar lichen sclerosus and lichen planus. Dermatol Ther. 2010; 23(5): 523–532. PMID: 20868406;
[56] Pukall CF, Goldstein AT, Bergeron S, et al. Vulvodynia: definition, diagnosis and treatment. Clin Obstet Gynecol. 2016; 9(3): 453–466. PMID: 26944461;
[57] Bohm-Starke N, Hilliges M, Brodda-Jansen G, Rylander E, Falconer C. Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain. 2001; 94(2): 177–183. PMID: 11690728;
[58] Sutton KS, Pukall CF. Painful intercourse, dyspareunia, and vulvodynia: a review of recent literature. Curr Sex Health Rep. 2014; (4): 59–267. PMID: 25598784;
[59] Reissing ED, Brown C, Lord MJ, Binik YM, Khalifé S. Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. J Psychosom Obstet Gynaecol. 2005; 26(2): 107–113. PMID: 16050536;
[60] Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med. 2013; 10(7): 1790–1799. PMID: 23679050;
[61] Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society. Maturitas. 2014; 79(3): 349–354. PMID: 25160739;
[62] Pukall CF, Bergeron S, Khalifé S, et al. Vulvar vestibulitis syndrome: comparative psychological and psychophysical data in a national sample. Obstet Gynecol. 2002; 100(4): 823–828. PMID: 12383551;
[63] Desrochers G, Bergeron S, Khalifé S, Dupuis MJ, Jodoin M. Fear avoidance and self-efficacy in relation to pain and sexual impairment in women with provoked vestibulodynia. Clin J Pain. 2009; 25(6): 520–527. PMID: 19542801;
[64] Schlaeger JM, Sjoberg L, Grafton B, Coleman S. Mindfulness meditation and cognitive behavioral therapy for chronic pain management in vulvodynia: a literature review. J Midwifery Womens Health. 2017; 62(6): 706–718. PMID: 29178560;
[65] Marinoff SC, Turner ML. Vulvar vestibulitis syndrome: an overview. Am J Obstet Gynecol. 1991; 165(4 Pt 2): 1228–1233. PMID: 1659198;
[66] Schnatz PF, Mandavilli S, Nelson EL, Schocken DD, O’Sullivan DM. Vulvodynia in a general gynecology practice: a survey of prevalence and characteristics. J Reprod Med. 2006; 51(10): 837–842. PMID: 17165406.
[67] Goetsch MF. Dyspareunia: causes and treatments. Obstet Gynecol. 2007; 109(2 Pt 1): 465–476. PMID: 17267845;
[68] Bohm-Starke N. Clinical and neurophysiological evidence of vestibular hyperalgesia in vulvar vestibulitis. Reg Anesth Pain Med. 1999; 24(4): 256–260. PMID: 10428299;
[69] Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Increased blood flow and nerve proliferation in the vestibular mucosa in vulvar vestibulitis. Obstet Gynecol. 1999; 93(2): 258–262. PMID: 9932566;
[70] Foster DC, Kotok MB, Huang LS, et al. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2010; 116(3): 583–593. PMID: 20733439;
[71] Reed BD, Harlow SD, Legocki LJ, et al. Sexual pain and genital symptoms among women with vulvodynia: are they really distinct conditions? J Sex Med. 2012; 9(3): 873–879. PMID: 22248228;
[72] Nyirjesy P, Peyton C, Weitz MV, Mathew L. Over-the-counter and alternative medicines in the treatment of chronic vaginal symptoms. Obstet Gynecol. 1999; 94(5 Pt 1): 769–772. PMID: 10546724;
[73] Pukall CF, Young RA, Roberts C, Sutton KS, Smith KB. Physical therapy and psychological interventions for provoked vestibulodynia: an integrative review. Clin J Pain. 2019; 35(6): 509–523. PMID: 30768568;
[74] Mitchell CM, Reed BD, Harlow SD, Haefner HK. Urinary tract infections and urogenital symptoms in women with vulvodynia. J Womens Health (Larchmt). 2008; 17(1): 125–131. PMID: 18240984;
[75] Brown C, Wan J, Reissing ED. Exercise-induced vulvar pain in women with and without provoked vestibulodynia: a case-control study. Pain Med. 2021; 22(5): 1127–1135. PMID: 33021699;
[76] Nguyen RHN, Mathur C, Wynne C, Harlow BL. Perceived triggers of vulvodynia: do women agree? J Reprod Med. 2013; 58(11–12): 504–512. PMID: 24494313
[77] Pukall CF, Binik YM, Khalifé S, Amsel R, Abbott FV. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain. 2002; 96(1–2): 163–175. PMID: 11932072;
[78] Reed BD, Haefner HK, Punch MR, Roth RS, Gorenflo DW. Psychosocial and sexual functioning in women with vulvodynia. J Reprod Med. 2000; 45(9): 702–706. PMID: 11077637.
[79] Goldstein A, Burrows LJ. Vulvodynia. J Sex Med. 2008; 5(5): 1037–1045. PMID: 18173761;
[80] Edwards L. Vulvodynia. Clin Obstet Gynecol. 2015; 58(1): 143–152. PMID: 25608256.
[81] Tommola P, Unkila-Kallio L, Paavonen J, Meri S. Complement membrane attack complex is found in lichen sclerosus-associated vulvar carcinoma but not in lichen sclerosus. Gynecol Oncol. 2012; 126(2): 245–249. PMID: 22516020;
[82] Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Neurochemical characterization of the vestibular nerves in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest. 2005; 59(2): 75–80. PMID: 15627717;
[83] Reissing ED, Binik YM, Khalifé S, Cohen D, Amsel R. Vaginal and pelvic muscle responses to sexual and nonsexual stimuli in women with vulvar vestibulitis syndrome. J Sex Med. 2005; 2(2): 338–343. PMID: 16422802;
[84] Pukall CF, Goldstein AT, Bergeron S. Vulvodynia: multidisciplinary approaches to treatment. In: Goldstein I, et al., eds. Women’s Sexual Function and Dysfunction: Study, Diagnosis and Treatment. 2nd ed. London: Taylor & Francis; 2012. p. 583–597.
Cite This Article
  • APA Style

    Harni, V., Babic, D., Hadzavdic, S. L., Barisic, D., Karadza, M. (2025). Chronic Vulvar Discomfort: Clinical Profiles, Pain Mapping, and Diagnostic Insights. Journal of Gynecology and Obstetrics, 13(3), 35-47. https://doi.org/10.11648/j.jgo.20251303.11

    Copy | Download

    ACS Style

    Harni, V.; Babic, D.; Hadzavdic, S. L.; Barisic, D.; Karadza, M. Chronic Vulvar Discomfort: Clinical Profiles, Pain Mapping, and Diagnostic Insights. J. Gynecol. Obstet. 2025, 13(3), 35-47. doi: 10.11648/j.jgo.20251303.11

    Copy | Download

    AMA Style

    Harni V, Babic D, Hadzavdic SL, Barisic D, Karadza M. Chronic Vulvar Discomfort: Clinical Profiles, Pain Mapping, and Diagnostic Insights. J Gynecol Obstet. 2025;13(3):35-47. doi: 10.11648/j.jgo.20251303.11

    Copy | Download

  • @article{10.11648/j.jgo.20251303.11,
      author = {Vesna Harni and Damir Babic and Suzana Ljubojevic Hadzavdic and Dubravko Barisic and Magdalena Karadza},
      title = {Chronic Vulvar Discomfort: Clinical Profiles, Pain Mapping, and Diagnostic Insights
    },
      journal = {Journal of Gynecology and Obstetrics},
      volume = {13},
      number = {3},
      pages = {35-47},
      doi = {10.11648/j.jgo.20251303.11},
      url = {https://doi.org/10.11648/j.jgo.20251303.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jgo.20251303.11},
      abstract = {This study provides a comprehensive clinical evaluation of women with chronic vulvar discomfort (CVD), focusing on two primary conditions underlying these symptoms: vulvodynia and vulvar dermatoses. A total of 328 women were enrolled in the DATRIV study (Diagnostic Accuracy of Three Rings Vulvoscopy) and categorized into four clinical groups: asymptomatic women with a normal vulva, asymptomatic women with impaired vulvar skin, and symptomatic patients diagnosed with either vulvodynia or vulvar dermatosis. Each participant underwent structured symptom profiling, sexual activity assessment, and targeted pain localization using the cotton-swab (Q-tip) test, systematically applied across a novel three-ring anatomical model (outer, middle, and inner vulvar rings). Pain response was further mapped using a clock-face method. Dyspareunia severity was graded with the Marinoff Index, and potential symptom triggers were explored through standardized behavioral and environmental questionnaires. Clinical data were analyzed using StatSoft, Statistica 12, and SPSS 20. The Institutional Review Board of Polyclinic Harni approved the study, and all participants provided written informed consent. Findings showed that 100% of women with vulvodynia and 80.5% of those with vulvar dermatoses experienced dyspareunia (Marinoff grades 1–3), in contrast to only 1.3% of asymptomatic controls. Marinoff Index 2 (pain that occasionally prevents intercourse) was observed in 54.8% of vulvodynia and 52.9% of dermatosis patients. In comparison, Marinoff Index 3 (pain that completely precludes intercourse) was present in 15.1% and 26.5%, respectively. Pain mapping revealed that the inner vulvar ring, especially at 4, 6, and 8 o’clock, was the most pain-sensitive region in patients with vulvodynia, consistent with localized nociceptor hypersensitivity. Environmental and behavioral triggers—such as menstruation (54.9% in vulvodynia vs. 36.5% in dermatosis), tampon use (65.9% vs. 42.8%), urination-related discomfort (47.6% vs. 36.6%), cycling (61.9% vs. 47.4%), and tight clothing (reported symptom aggravation in 85.4% of vulvodynia patients vs. 46.3% of dermatosis patients)—were frequently identified, reflecting distinct trigger profiles between the conditions. This study highlights the diagnostic value of combining the Marinoff Index and cotton-swab test with structured pain mapping using the three-ring vulvar model and clock-face method. Together, these tools offer a reproducible and clinically meaningful framework for identifying vulvar pain phenotypes, enabling more individualized and effective therapeutic strategies for women with chronic vulvar pain syndromes.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Chronic Vulvar Discomfort: Clinical Profiles, Pain Mapping, and Diagnostic Insights
    
    AU  - Vesna Harni
    AU  - Damir Babic
    AU  - Suzana Ljubojevic Hadzavdic
    AU  - Dubravko Barisic
    AU  - Magdalena Karadza
    Y1  - 2025/05/22
    PY  - 2025
    N1  - https://doi.org/10.11648/j.jgo.20251303.11
    DO  - 10.11648/j.jgo.20251303.11
    T2  - Journal of Gynecology and Obstetrics
    JF  - Journal of Gynecology and Obstetrics
    JO  - Journal of Gynecology and Obstetrics
    SP  - 35
    EP  - 47
    PB  - Science Publishing Group
    SN  - 2376-7820
    UR  - https://doi.org/10.11648/j.jgo.20251303.11
    AB  - This study provides a comprehensive clinical evaluation of women with chronic vulvar discomfort (CVD), focusing on two primary conditions underlying these symptoms: vulvodynia and vulvar dermatoses. A total of 328 women were enrolled in the DATRIV study (Diagnostic Accuracy of Three Rings Vulvoscopy) and categorized into four clinical groups: asymptomatic women with a normal vulva, asymptomatic women with impaired vulvar skin, and symptomatic patients diagnosed with either vulvodynia or vulvar dermatosis. Each participant underwent structured symptom profiling, sexual activity assessment, and targeted pain localization using the cotton-swab (Q-tip) test, systematically applied across a novel three-ring anatomical model (outer, middle, and inner vulvar rings). Pain response was further mapped using a clock-face method. Dyspareunia severity was graded with the Marinoff Index, and potential symptom triggers were explored through standardized behavioral and environmental questionnaires. Clinical data were analyzed using StatSoft, Statistica 12, and SPSS 20. The Institutional Review Board of Polyclinic Harni approved the study, and all participants provided written informed consent. Findings showed that 100% of women with vulvodynia and 80.5% of those with vulvar dermatoses experienced dyspareunia (Marinoff grades 1–3), in contrast to only 1.3% of asymptomatic controls. Marinoff Index 2 (pain that occasionally prevents intercourse) was observed in 54.8% of vulvodynia and 52.9% of dermatosis patients. In comparison, Marinoff Index 3 (pain that completely precludes intercourse) was present in 15.1% and 26.5%, respectively. Pain mapping revealed that the inner vulvar ring, especially at 4, 6, and 8 o’clock, was the most pain-sensitive region in patients with vulvodynia, consistent with localized nociceptor hypersensitivity. Environmental and behavioral triggers—such as menstruation (54.9% in vulvodynia vs. 36.5% in dermatosis), tampon use (65.9% vs. 42.8%), urination-related discomfort (47.6% vs. 36.6%), cycling (61.9% vs. 47.4%), and tight clothing (reported symptom aggravation in 85.4% of vulvodynia patients vs. 46.3% of dermatosis patients)—were frequently identified, reflecting distinct trigger profiles between the conditions. This study highlights the diagnostic value of combining the Marinoff Index and cotton-swab test with structured pain mapping using the three-ring vulvar model and clock-face method. Together, these tools offer a reproducible and clinically meaningful framework for identifying vulvar pain phenotypes, enabling more individualized and effective therapeutic strategies for women with chronic vulvar pain syndromes.
    
    VL  - 13
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Sections